Circulating NGAL as a multipurpose biomarker in patients hospitalized for acute decompensation of cirrhosis​Elayne Cristina de Morais Rateke Camila Matiollo Emerita Quintina de Andrade Moura Michelle Andrigueti Claudia Maccali Janaína Sant’Ana Fonseca Sabine Machado Fiorenza Canova Janaína Luz Narciso-Schiavon Leonardo Lucca Schiavon a Unidade de Laboratório de Análises Clínicas, Hospital Universitário, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazilb Divisão de Gastroenterologia, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazilon November 19, 2025 at 2:31 am

Volume 85, Issue 8, DECEMBER 2025, Page 636-647.

Sample stability of forty-two analytes in plasma or serum pools after one to four repeated −80 °C freeze-thaw cycles​Gustav Mikkelsen Ketil Thorstensen Ingrid Alsos Lian Lena Løfblad Gunhild Garmo Hov Arne Åsberg a Department of Laboratory Medicine, Clinical Chemistry, Trondheim University Hospital, Trondheim, Norwayb Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norwayon December 22, 2025 at 5:15 am

Volume 85, Issue 8, DECEMBER 2025, Page 695-701.

Strategy of Laboratory Medicine – EFLM VisionMario Plebanion December 29, 2025 at 11:00 am

Clin Chem Lab Med. 2025 Dec 30. doi: 10.1515/cclm-2025-1678. Online ahead of print. ABSTRACT The strategic direction of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) is guided by global healthcare trends, rapid technological advancements, and the evolving role of laboratory professionals in modern medicine. The aim is to position laboratory medicine as … Read more

Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosisSimone Marchesellion December 27, 2025 at 11:00 am

Clin Chem Lab Med. 2025 Dec 29. doi: 10.1515/cclm-2025-1339. Online ahead of print. ABSTRACT OBJECTIVES: The Kappa Index has proven its diagnostic value for multiple sclerosis (MS), while its prognostic potential remains to be fully explored. The objective of this study is thus to investigate the value of the Kappa Index at disease onset in … Read more

From automation to agentic artificial intelligence in laboratory medicine: an opinion of the IFCC Division on Emerging TechnologiesDamien Grusonon December 27, 2025 at 11:00 am

Clin Chem Lab Med. 2025 Dec 29. doi: 10.1515/cclm-2025-1314. Online ahead of print. ABSTRACT Agentic artificial intelligence (AI) systems are distinguished by their ability to invoke multiple tools, compose command chains, and combine chain-of-thought reasoning with deep research to execute complex tasks and take actions. This represents a major evolution beyond machine learning and large … Read more

Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controlsEline A J Willemseon December 26, 2025 at 11:00 am

Clin Chem Lab Med. 2025 Dec 29. doi: 10.1515/cclm-2025-1480. Online ahead of print. ABSTRACT OBJECTIVES: Compare Elecsys (Roche) and Simoa (Quanterix) immunoassays for serum glial fibrillary acidic protein (GFAP) using our reference database and Z scores, and evaluate their prognostic value for progression independent of relapse activity (PIRA) in multiple sclerosis (MS). METHODS: Platform correlation … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520